Related Experiment Video
Updated: Jun 18, 2025

Screening Assays to Characterize Novel Endothelial Regulators Involved in the Inflammatory Response
Published on: September 15, 2017
Multidisciplinary management of type 2 inflammation diseases using a screening tool
Oscar Palomares1, Carolina Cisneros2, Francisco Javier Ortiz de Frutos3
1Department of Biochemistry and Molecular Biology, School of Chemistry, Complutense University of Madrid, Madrid, Spain.
Type 2 (T2) immune response dysregulation causes inflammation and coexisting diseases. A new questionnaire helps screen for multiple T2-related conditions, improving diagnosis and care.
Area of Science:
- Immunology
- Allergy
- Pulmonology
- Dermatology
- Otorhinolaryngology
Background:
- Dysregulation of the type 2 (T2) immune response underlies various organ-specific inflammatory diseases.
- Coexisting T2-related disorders are common but often overlooked due to fragmented care and diagnostic challenges.
- Mild T2 dysregulation may not be initially suspected, leading to delayed diagnosis and suboptimal patient management.
Purpose of the Study:
- To identify cardinal symptoms of common T2 inflammation-related diseases.
- To develop a simple, patient-friendly screening tool for coexisting T2 diseases.
- To facilitate early detection and appropriate specialist referral for patients with T2 dysregulation.
Main Methods:
- A multidisciplinary expert group compiled a list of key symptoms from patients with T2 inflammation-related conditions.
- The identified symptoms were used to create a questionnaire for initial patient screening.
- The proposed questionnaire is designed for administration at any healthcare level.
Main Results:
- A comprehensive list of cardinal symptoms associated with T2 inflammation-related diseases was established.
- A patient-friendly questionnaire was developed based on these symptoms.
- The questionnaire aims to facilitate the identification of patients with potential coexisting T2 diseases.
Conclusions:
- Early screening for T2 inflammation-related diseases is crucial for timely diagnosis and management.
- The developed questionnaire offers a practical tool for identifying patients who may benefit from specialist evaluation.
- Improved interdisciplinary communication and screening tools can enhance care coordination for patients with T2 dysregulation.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:

